As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Immunoglobulin Market: By Application: Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS, Others; By Route of Administration; By Clinical Trial; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Immunoglobulin Market Outlook

The global immunoglobulin market attained a value of about USD 11.9 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 7.1% to reach approximately USD 18 billion by 2026.

 

Rising Applications of Immunoglobulin in Hypogammaglobulinemia to Boost the Global Market

North America is considered the dominant regional market for immunoglobulin, owing to the rapid development of antibody therapy in the healthcare sector within the region. During the onset of the coronavirus pandemic, the region witnessed a massive increase in clinical trials of immunoglobulins across various phases of development, which aided the market as a prominent driving factor. The active and dynamic market for pharmaceuticals in the region facilitates multiple beneficial mergers and acquisitions, which subsequently fuels this trend of growth.

 

Global Immunoglobulin Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By the route of administration, the market share held by the intravenous segment is multiple folds larger than that hold by the subcutaneous segment, mainly due to the high availability of products and rapid absorption rate in the intravenous form. Moreover, immunoglobulin finds its application across various conditions, among which hypogammaglobulinemia is estimated to continue its dominance in the global market owing to the significant increase in the prevalence of the associated disorder over the years.

 

Immunoglobulin: Industry Definition and Segmentation

An immunoglobulin, also termed an antibody, is a protein biologically produced by plasma cells and other lymphocytes, which is used by the immune system to detect and destroy disease-causing pathogens. Commercial immunoglobulin is a blood product obtained through the process of fractionation and purification for therapeutic and research applications.

The major applications of immunoglobulin are:

  • Hypogammaglobulinemia
  • CIPD
  • Immunodeficiency Diseases
  • Congenital AIDS
  • Chronic Lymphocytic Leukaemia
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • ITP
  • Kawasaki Disease
  • Guillain-Barre Syndrome

Based on route of administration, the industry is segmented into:

  • Intravenous
  • Subcutaneous

The market can be broadly categorised on the basis of clinical trial into:

  • IgG
  • IgA
  • IgM
  • IgE
  • IgD

The EMR report looks into the regional markets of immunoglobulin like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Prevalence of Immunodeficient and Neurological Diseases to Provide Lucrative Opportunities for Immunoglobulin Industry Growth

The global market for immunoglobulin is mainly propelled by the rise in prevalence of immunodeficiency diseases and the emergence of enhanced purification techniques which offer a better yield of plasma. Furthermore, spatial genomic analysis, aided by immunoglobulins, yields a biomarker for cancer diagnostics, whose rising demand is expected to boost the market growth for immunoglobulins. The products also find use in the treatment of neurological disorders, which acts as an additional driving force for the demand growth. Moreover, improvements in the research and development sector for the creation of new products for the control of diseases is expected to drive market growth. Meanwhile, the existence of certain side effects associated with the use of immunoglobulins, and the resultant stringent government policies, are some of the few factors which can be considered as obstacles. However, with time, scientific advancements are likely to counter them and pave the way for robust market growth.

 

Key Industry Players in the Global Immunoglobulin Market

The report presents a detailed analysis of the following key players in the global immunoglobulin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Biotest AG
  • Octapharma AG
  • Baxter International Inc.
  • China Biologics Products Inc.
  • Grifols SA

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and
Forecast Market Analysis by Segment- Application, Route of Administration, Clinical Trial, Region
Breakup by Application Hypogammaglobulinemia, CIPD, Immunodeficiency Diseases, Congenital AIDS,
Chronic Lymphocytic Leukaemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome
Breakup by Route of Administration Intravenous, Subcutaneous
Breakup by Clinical Trial IgG, IgA, IgM, IgE, IgD
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., Grifols SA
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Immunoglobulin Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Immunoglobulin Historical Market (2016-2020) 
    8.3    Global Immunoglobulin Market Forecast (2021-2026)
    8.4    Global Immunoglobulin Market by Application
        8.4.1    Hypogammaglobulinemia
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    CIPD
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
        8.4.3    Immunodeficiency Diseases
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
        8.4.4    Congenital AIDS
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
        8.4.5    Chronic Lymphocytic Leukaemia
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
        8.4.6    Myasthenia Gravis
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
        8.4.7    Multifocal Motor Neuropathy
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2016-2020)
            8.4.7.3    Forecast Trend (2021-2026)
        8.4.8    ITP
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2016-2020)
            8.4.8.3    Forecast Trend (2021-2026)
        8.4.9    Kawasaki Disease
            8.4.9.1    Market Share
            8.4.9.2    Historical Trend (2016-2020)
            8.4.9.3    Forecast Trend (2021-2026)
        8.4.10    Guillain-Barre Syndrome
            8.4.10.1    Market Share
            8.4.10.2    Historical Trend (2016-2020)
            8.4.10.3    Forecast Trend (2021-2026)
    8.5    Global Immunoglobulin Market by Route of Administration
        8.5.1    Intravenous
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Subcutaneous
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
    8.6    Global Immunoglobulin Market by Clinical Trial
        8.6.1    IgG
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    IgA
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
        8.6.3    IgM
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2016-2020)
            8.6.3.3    Forecast Trend (2021-2026)
        8.6.4    IgE
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2016-2020)
            8.6.4.3    Forecast Trend (2021-2026)
        8.6.5    IgD
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2016-2020)
            8.6.5.3    Forecast Trend (2021-2026)
    8.7    Global Immunoglobulin Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
        10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Biotest AG
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Octapharma AG
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Baxter International Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    China Biologics Products Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Grifols SA
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
13    Industry Events and Developments

 

Additional Customisations Available

1    Manufacturing Process
    1.1    Overview
    1.2    Detailed Process Flow
    1.3    Operation Involved
2    Project Requirement and Cost Analysis
    2.1    Land, Location and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Material
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investment

 

List of Figures and Tables

1.    Global Immunoglobulin Market: Key Industry Highlights, 2016 and 2026
2.    Global Immunoglobulin Historical Market: Breakup by Application (USD Billion), 2016-2020
3.    Global Immunoglobulin Market Forecast: Breakup by Application (USD Billion), 2021-2026
4.    Global Immunoglobulin Historical Market: Breakup by Route of Administration (USD Billion), 2016-2020
5.    Global Immunoglobulin Market Forecast: Breakup by Route of Administration (USD Billion), 2021-2026
6.    Global Immunoglobulin Historical Market: Breakup by Clinical Trial (USD Billion), 2016-2020
7.    Global Immunoglobulin Market Forecast: Breakup by Clinical Trial (USD Billion), 2021-2026
8.    Global Immunoglobulin Historical Market: Breakup by Region (USD Billion), 2016-2020
9.    Global Immunoglobulin Market Forecast: Breakup by Region (USD Billion), 2021-2026
10.    North America Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2016-2020
11.    North America Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2021-2026
12.    Europe Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2016-2020
13.    Europe Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2021-2026
14.    Asia Pacific Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2016-2020
15.    Asia Pacific Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2021-2026
16.    Latin America Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2016-2020
17.    Latin America Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2021-2026
18.    Middle East and Africa Immunoglobulin Historical Market: Breakup by Country (USD Billion), 2016-2020
19.    Middle East and Africa Immunoglobulin Market Forecast: Breakup by Country (USD Billion), 2021-2026
20.    Global Immunoglobulin Market Structure

Key Questions Answered in the Report

The global immunoglobulin market attained a value of nearly USD 11.9 billion in 2020.

The market is projected to grow at a CAGR of 7.1% in the forecast period of 2021-2026.

The market is estimated to witness healthy growth in the forecast period of 2021-2026 to reach about USD 18 billion by 2026.

The immunoglobulin industry is being driven by rapid clinical trials with the outburst of coronavirus pandemic, rise in prevalence of immunodeficiency diseases, and the emergence of enhanced purification techniques.

The market is positively influenced by the applications of immunoglobulin in treatment of various neurological disorders and the prevalence of immunodeficient diseases.

The major regional markets for immunoglobulin are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Immunoglobulin finds its applications in hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukaemia, myasthenia gravis, multifocal motor neuropathy, ITP, kawasaki disease, and guillain-barre syndrome.

The major routes of administration of immunoglobulin are intravenous and subcutaneous.

On the basis of clinical trial, the market can be categorised into IgG, IgA, IgM, IgE, and IgD.

The major players in the industry are Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., and Grifols SA.

Analyst Review

The global immunoglobulin market attained a value of about USD 11.9 billion by 2020, driven by the presence of prominent industry players. Aided by improvements in the R&D sector for treatment of various diseases, the market is expected to grow at a CAGR of 7.1% in the forecast period of 2021-2026 to reach nearly USD 18 billion by 2026.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of applications, the industry can be segmented into hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukaemia, myasthenia gravis, multifocal motor neuropathy, ITP, kawasaki disease and, guillain-barre syndrome. On the basis of mode of administration, the market can be divided into intravenous and subcutaneous. Based on clinical trial, the market segmentations include IgG, IgA, IgM, IgE, and IgD. The major regional markets for Immunoglobulin are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Biotest AG, Octapharma AG, Baxter International Inc., China Biologics Products Inc., and Grifols SA.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER